Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.870
-0.130 (-4.33%)
Mar 3, 2026, 4:00 PM EST - Market closed

Organogenesis Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
564.17482.04433.14450.89467.36
Revenue Growth (YoY)
17.04%11.29%-3.94%-3.52%38.15%
Cost of Revenue
137.52115.74106.48105.02114.2
Gross Profit
426.65366.3326.66345.87353.16
Selling, General & Admin
326.24294.51269.75283.81250.2
Research & Development
44.5450.2744.3839.7630.74
Other Operating Expenses
11.1822.8---
Total Operating Expenses
381.95367.59314.13323.57280.94
Operating Income
44.69-1.2812.5322.372.22
Interest Expense
2.28-1.54-2.19-2.01-7.24
Other Non-Operating Income (Expense)
-0.010.020.06-0.01-1.9
Total Non-Operating Income (Expense)
2.28-1.52-2.13-2.02-9.13
Pretax Income
46.97-2.8110.3920.2863.09
Provision for Income Taxes
9.94-3.675.454.75-31.12
Net Income
20.02-0.944.9515.5394.2
Net Income Attributable to Preferred Dividends
-17.01-1.8---
Net Income to Common
20.02-0.944.9515.5394.2
Net Income Growth
---68.16%-83.51%446.61%
Shares Outstanding (Basic)
127132131130128
Shares Outstanding (Diluted)
130132133132134
Shares Change (YoY)
-1.08%-0.81%0.27%-0.96%20.03%
EPS (Basic)
0.16-0.010.040.120.73
EPS (Diluted)
0.15-0.010.040.120.70
EPS Growth
---66.67%-82.86%366.67%
Free Cash Flow
-3.77-0.87-21.23-9.0430.76
Free Cash Flow Per Share
-0.03-0.01-0.16-0.070.23
Gross Margin
75.62%75.99%75.42%76.71%75.57%
Operating Margin
7.92%-0.27%2.89%4.95%15.45%
Profit Margin
6.56%0.18%1.14%3.44%20.16%
FCF Margin
-0.67%-0.18%-4.90%-2.00%6.58%
EBITDA
71.6324.0935.9740.3488.89
EBITDA Margin
12.70%5.00%8.31%8.95%19.02%
EBIT
44.69-1.2812.5322.372.22
EBIT Margin
7.92%-0.27%2.89%4.95%15.45%
Effective Tax Rate
21.16%130.67%52.42%23.42%-49.32%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q